Commission Implementing Regulation (EU) 2021/620 of 15 April 2021 laying down rul... (32021R0620)
INHALT
Commission Implementing Regulation (EU) 2021/620 of 15 April 2021 laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council as regards the approval of the disease-free and non-vaccination status of certain Member States or zones or compartments thereof as regards certain listed diseases and the approval of eradication programmes for those listed diseases (Text with EEA relevance)
- COMMISSION IMPLEMENTING REGULATION (EU) 2021/620
- of 15 April 2021
- laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council as regards the approval of the disease-free and non-vaccination status of certain Member States or zones or compartments thereof as regards certain listed diseases and the approval of eradication programmes for those listed diseases
- (Text with EEA relevance)
- Article 1
- Subject matter and scope
- Article 2
- Infection with
- Brucella abortus
- ,
- B. melitensis
- and
- B. suis
- Article 3
- Infection with Mycobacterium tuberculosis complex (
- M. bovis, M. caprae
- and
- M. tuberculosis
- ) (MTBC)
- Article 4
- Infection with rabies virus (RABV)
- Article 5
- Enzootic bovine leukosis (EBL)
- Article 6
- Infectious bovine rhinotracheitis/infectious pustular vulvovaginitis (IBR/IPV)
- Article 7
- Infection with Aujeszky’s disease virus(ADV)
- Article 8
- Bovine viral diarrhoea (BVD)
- Article 9
- Infection with bluetongue virus (serotypes 1-24) (infection with BTV)
- Article 10
- Infestation with
- Varroa
- spp.
- Article 11
- Infection with Newcastle disease virus
- Article 12
- Infection with highly pathogenic avian influenza (HPAI)
- Article 13
- Viral haemorrhagic septicaemia (VHS)
- Article 14
- Infectious haematopoietic necrosis (IHN)
- Article 15
- Infection with highly polymorphic region deleted infectious salmon anaemia virus (HPR-deleted ISAV)
- Article 16
- Infection with
- Marteilia refringens
- Article 17
- Infection with
- Bonamia exitiosa
- Article 18
- Infection with
- Bonamia ostreae
- Article 19
- Infection with white spot syndrome virus (WSSV)
- Article 20
- Repeal
- Article 21
- Entry into force and application
- ANNEX I
- INFECTION WITH
- BRUCELLA ABORTUS, B. MELITENSIS
- AND
- B. SUIS
- PART I
- Disease-free status from infection with
- Brucella abortus, B. melitensis
- and
- B. suis
- CHAPTER 1
- Member States or zones thereof with disease-free status from infection with
- Brucella abortus, B. melitensis
- and
- B. suis
- in bovine animal populations
- CHAPTER 2
- Member States or zones thereof with disease-free status from infection with
- Brucella abortus, B. melitensis
- and
- B. suis
- in ovine and caprine animal populations
- PART II
- Member States or zones thereof with an approved eradication programme for
- Brucella abortus, B. melitensis
- and
- B. suis
- ANNEX II
- INFECTION WITH
- MYCOBACTERIUM TUBERCULOSIS COMPLEX (M. BOVIS, M. CAPRAE
- AND
- M. TUBERCULOSIS)
- (MTBC)
- PART I
- Member States or zones thereof with disease-free status from MTBC
- PART II
- Member States or zones thereof with an approved eradication programme for infection with MTBC
- ANNEX III
- INFECTION WITH THE RABIES VIRUS (RABV)
- PART I
- Member States or zones thereof with disease-free status from infection with RABV
- PART II
- Member States or zones thereof with an approved eradication programme for infection with RABV
- ANNEX IV
- ENZOOTIC BOVINE LEUKOSIS (EBL)
- PART I
- Member States or zones thereof with disease-free status from EBL
- PART II
- Member States or zones thereof with an approved eradication programme for EBL
- ANNEX V
- INFECTIOUS BOVINE RHINOTRACHEITIS/INFECTIOUS PUSTULAR VULVOVAGINITIS (IBR/IPV)
- PART I
- Member States or zones thereof with disease-free status from IBR/IPV
- PART II
- Member States or zones thereof with an approved eradication programme for IBR/IPV
- ANNEX VI
- AUJESZKY’S DISEASE VIRUS (ADV)
- PART I
- Member States or zones thereof with disease-free status from infection with ADV
- PART II
- Member States or zones thereof with an approved eradication programme for infection with ADV
- ANNEX VII
- BOVINE VIRAL DIARRHOEA (BVD)
- PART I
- Member States or zones thereof with disease-free status from with BVD
- PART II
- Member States or zones thereof with an approved eradication programme for BVD
- ANNEX VIII
- INFECTION WITH BLUETONGUE VIRUS (BTV)
- PART I
- Member States or zones thereof with disease-free status from infection with BTV
- PART II
- Member States or zones thereof with an approved eradication programme for infection with BTV
- ANNEX IX
- INFESTATION WITH
- VARROA
- SPP.
- Member States or zones thereof with disease-free status from infestation with
- Varroa
- spp.
- ANNEX X
- INFECTION WITH NEWCASTLE DISEASE VIRUS
- Member States or zones thereof with disease-free status from infection with Newcastle disease virus without vaccination
- ANNEX XI
- HIGHLY PATHOGENIC AVIAN INFLUENZA (HPAI)
- Compartments free from HPAI
- ANNEX XII
- VIRAL HAEMORRHAGIC SEPTICAEMIA (VHS)
- PART I
- Member States whose whole territory has disease-free status from VHS;
- zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from VHS; and
- zones or compartments of Member States with disease-free status from VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
- PART II
- Member States where their whole territory has an approved eradication programme for VHS;
- zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for VHS;
- and zones and compartments of Member States with an approved eradication programme for VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
- ANNEX XIII
- INFECTIOUS HAEMATOPOIETIC NECROSIS (IHN)
- PART I
- Member States where their whole territory has disease-free status from IHN;
- zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from IHN;
- and zones or compartments of Member States with disease-free status from IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
- PART II
- Member States where their whole territory has an approved eradication programme for IHN;
- zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for IHN; and
- zones and compartments of Member States with an approved eradication programme for IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
- ANNEX XIV
- INFECTION WITH HIGHLY POLYMORPHIC REGION DELETED INFECTIOUS SALMON ANAEMIA VIRUS (HPR-DELETED ISAV)
- PART I
- Member States where their whole territory has disease-free status from infection with HPR-deleted ISAV;
- zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with HPR-deleted ISAV; and
- zones or compartments of Member States with disease-free status from infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
- PART II
- Member States where their whole territory has an approved eradication programme for infection with HPR-deleted ISAV;
- zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with HPR-deleted ISAV; and
- zones and compartments of Member States with an approved eradication programme for infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
- ANNEX XV
- INFECTION WITH
- MARTEILIA REFRINGENS
- PART I
- Member States where their whole territory has disease-free status from infection with
- Marteilia refringens
- ;
- zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with
- Marteilia refringens;
- and
- zones or compartments of Member States with disease-free status from infection with
- Marteilia refringens,
- where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
- PART II
- Member States where their whole territory has an approved eradication programme for infection with
- Marteilia refringens
- ;
- zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with
- Marteilia refringens;
- and
- zones and compartments of Member States with an approved eradication programme for infection with
- Marteilia refringens
- , where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
- ANNEX XVI
- INFECTION WITH
- BONAMIA EXITIOSA
- PART I
- Member States where their whole territory has disease-free status from infection with
- Bonamia exitiosa
- ;
- zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with
- Bonamia exitiosa;
- and
- zones or compartments of Member States with disease-free status from infection with
- Bonamia exitiosa,
- where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
- PART II
- Member States where their whole territory has an approved eradication programme for infection with
- Bonamia exitiosa
- ;
- zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with
- Bonamia exitiosa;
- and
- zones and compartments of Member States with an approved eradication programme for infection with
- Bonamia exitiosa
- , where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
- ANNEX XVII
- INFECTION WITH
- BONAMIA OSTREAE
- PART I
- Member States where their whole territory has disease-free status from infection with
- Bonamia ostreae
- ;
- zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with
- Bonamia ostreae;
- and
- zones or compartments of Member States with disease-free status from infection with
- Bonamia ostreae,
- where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
- PART II
- Member States where their whole territory has an approved eradication programme for infection with
- Bonamia ostreae
- ;
- zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with
- Bonamia ostreae;
- and
- zones and compartments of Member States with an approved eradication programme for infection with
- Bonamia ostreae
- , where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
- ANNEX XVIII
- INFECTION WITH WHITE SPOT SYNDROME VIRUS (WSSV)
- PART I
- Member States where their whole territory has disease-free status from infection with WSSV;
- zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with WSSV; and
- zones or compartments of Member States with disease-free status from infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
- PART II
- Member States where their whole territory has an approved eradication programme for infection with WSSV;
- zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with WSSV; and
- zones and compartments of Member States with an approved eradication programme for infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Feedback